Adoption of prasugrel into routine practice: rationale and design of the Rijnmond Collective Cardiology Research (CCR) study in percutaneous coronary intervention for acute coronary syndromes

BACKGROUND: Platelet inhibition is crucial in reducing both short- and long-term atherothrombotic risks in patients with acute coronary syndromes (ACS) managed with percutaneous coronary intervention (PCI). Based on randomised trials, recent recommendations in the current guidelines include the endo...

Descripción completa

Detalles Bibliográficos
Autores principales: Yetgin, T., van der Linden, M. M. J. M., de Vries, A. G., Smits, P. C., Boersma, E., van Geuns, R.-J. M., Zijlstra, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bohn Stafleu van Loghum 2013
Materias:
Design Study Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3967557/
https://www.ncbi.nlm.nih.gov/pubmed/24072688
http://dx.doi.org/10.1007/s12471-013-0472-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3967557/
https://www.ncbi.nlm.nih.gov/pubmed/24072688
http://dx.doi.org/10.1007/s12471-013-0472-1

Ejemplares similares